Johnson & Johnson (JNJ +0.4%) receives a favorable Barron's write-up. The paper talks up...
Friday, June 22, 2012, 1:55 PM ET
Johnson & Johnson (JNJ +0.4%) receives a favorable Barron'swrite-up. The paper talks up J&J's 3.7% dividend yield, low P/E, diverse product line, and new drug launches, along with its recently-closed acquisition of medical device maker Synthes. (earlier)
This Market Current was sent to 23,507 people who get email alerts on JNJ.